Exploring the Ligandability of 53BP1 Through Fragment-Based Approaches

04 December 2024, Version 1

Abstract

53BP1 is a DNA damage response protein recruited to sites of double strand breaks through recognition of dimethylated lysine on histone 4 by its tandem Tudor domains. Like 53BP1, BRCA-1 plays a role in the regulation of DNA repair pathways, and BRCA-1 mutations have been strongly linked to breast and ovarian cancer. Interestingly, mice null for 53BP1 and BRCA-1 genes display minimal tumor formation, suggesting that the effects of deleterious BRCA-1 mutations could be prevented with potent 53BP1 small molecule antagonists. Herein, we describe a fragment screen that was used to identify compounds that bind to the 53BP1 Tudor domain and a chemoinformatic workflow to select near-neighbour analogues and establish Structure Activity Relationships for these binders. The marked affinity improvements of the analogues over their parent fragments highlights the developability of these series and the utility of this approach in discovering novel hit compounds for 53BP1 and other methyl-lysine reader proteins.

Keywords

53BP1
Fragment-Based Drug Design
Chemoinformatics
Fragment Screening
Epigenetics
Surface Plasmon Resonance
Nuclear Magnetic Resonance

Supplementary materials

Title
Description
Actions
Title
Exploring the ligandability of 53BP1 through Fragment Based Approaches Supporting Information
Description
The Supporting Information contains details of protein expression, crystallization & data collection conditions, assay protocols (NMR, SPR & ITC) and raw replicate data.
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.